MedPath

The Effect of Alginate Supplementation on Weight Management

Not Applicable
Recruiting
Conditions
Overweight and Obesity
Interventions
Dietary Supplement: Alginate
Other: Placebo
Registration Number
NCT04589273
Lead Sponsor
Newcastle University
Brief Summary

This project will assess the effect of the alginate (in a capsules) on the weight of generally healthy volunteers over a 12 week period.

To achieve this, will recruit 150 (non-smoking) generally healthy volunteers to attend the study centre on four separate occasions. Volunteers will be randomly allocated into active or placebo arm of the trial, both will receive capsules with the same appearance.

The volunteers will have their height, weight, waist circumference, body composition, and fasting levels of circulating glucose, triacylglycerol and cholesterol measured at each for the four visits.

Detailed Description

The study will last approximately 12 weeks depending on your availability.

Volunteers will be asked to come to the research facility in Newcastle University, before they have had any breakfast, on four separate occasions. The volunteers must not eat or drink anything (except water) after 8 pm the evening before they come in. This includes not drinking any alcohol, tea or coffee.

Each time the volunteers come in, their height (first assessment only), weight, waist circumference and body composition will be measured. Body composition is measured using scales which can determine the percentage of their body is fat or bone or muscle. This is done using a small harmless electrical current passing through their body, they will not detect or feel this at all. Their height will also be measured at the first visit. Cholesterol, triglyceride and glucose levels in the blood will also be measured at each visit. This will be done through a single finger prick blood sample.

Enough capsules will be given to the volunteers to last you four weeks at the first three visits. The capsules will be filled with either alginate or another dietary fibre believed to have no effect on weight management.

Volunteers will be asked to take four of these capsules with their three main meals per day over the 12 week study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
190
Inclusion Criteria
  • Generally healthy
  • BMI over 20
Exclusion Criteria
  • Pregnant, lactating,
  • BMI under 20

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Alginate capsuleAlginateThe participants of this arm will be give the alginate capsules
PlaceboPlaceboThe participants of this arm will be give the placebo capsules
Primary Outcome Measures
NameTimeMethod
Change in amount of body fat12 weeks

A change in body fat (as a percentage) as measured by impedance

Change in Weight12 weeks

A change in weight measured in kg

Secondary Outcome Measures
NameTimeMethod
Change in fasting Glucose12 weeks

A Change in fasting circulating glucose

Change in waist circumference12 weeks

A change in waist circumference measured in cm

Change in fasting Cholesterol12 weeks

A change in fasting circulating cholesterol

Change in fasting triacylglycerol12 weeks

A change in fasting circulating triacylglycerol

Trial Locations

Locations (1)

Newcastle University

🇬🇧

Newcastle, Tyne And Wear, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath